ABSTRACT
Antepartum monitoring of fetal heart rate throughout the last weeks of diabetic pregnancy revealed a significant restriction of the baseline irregularity towards the end of the antepartum period. The quantitative amount (in % of total recording time/week) of the patterns of reduced irregularity ('silent', 'narrowed undulatory') increased from the 34th to the 40th week of pregnancy whereas the amount of normal ('undulatory') irregularity became smaller. The results were discussed in regard of the disturbed fetoplacental unit in the diabetic pregnancy.
Subject(s)
Fetal Heart/physiopathology , Heart Rate , Pregnancy in Diabetics/physiopathology , Female , Gestational Age , Humans , Maternal-Fetal Exchange , Pregnancy , Pregnancy Trimester, Third , Prenatal CareABSTRACT
Newborn babies of diabetic mothers have a higher birth weight in comparison with newborns of nondiabetic mothers in the same gestational age (35. to 39. week). Body weight percentiles were estimated for new borns of diabetics (excluding stillborn babies), it was to be shown that birth weight lower than 2750 gm in the 38. to 39. gestational week (less than 10. percentile) characterizes "small for gestational age babies". Not any influence of maternal blood glucose values during the second part of pregnancy was to be seen. Severe toxaemias and vascular-renal complications (WHITE-class F) were statistically significant correlated with underweight in newborns. The lowest perinatal mortality was found in the weight class 3500 to 3999 gm.
Subject(s)
Birth Weight , Obstetric Labor Complications , Pregnancy in Diabetics , Female , Gestational Age , Humans , Infant Mortality , Infant, Newborn , Male , Pregnancy , Prenatal CareABSTRACT
During two years 73 insulindependent pregnant diabetics (43,2% of the total material) were treated with Dilatol (Buphenin) and Isoptin. The requirement of insulin increased dependent on the dosage and on the application of the tocolytic drugs. Despite the considerable influence on blood sugar it is possible to maintain metabolic conditions at normoglycaemic levels during short- or longterm tocolysis, provided exact metabolic controls and adapted insulin treatment. The prophylactic administration of contractionreducing drugs is indicated in pregnant diabetics.